The current treatment of pancreatic cancer is based on surgery and chemotherapy, but it is difficult to interpret the extent of the tumour from the images obtained by conventional techniques to decide whether or not to operate on patients. The study, with a duration of two years, responds to the need to scientifically validate the precision of three-dimensional (3D) imaging technology compared to conventional computed tomography (CT) in the preoperative staging of patients with borderline or locally advanced pancreatic adenocarcinoma (ACP).

The aim is to be able to more accurately determine which patients can have a pancreatic tumour successfully removed and which patients cannot, and thus avoid unnecessary surgery. This is a prospective, multicentre study in which 16 other reference centres in pancreatic surgery nationwide will participate.

Garcés and Dorcaratto are also researchers from the INCLIVA General and Digestive Surgery Research Group and associate physicians from the Hepato-Bilio-Pancreatic Surgery Unit of the General Surgery and Digestive System Service of the Clinical Hospital of Valencia.

The INCLIVA Health Research Institute, of the Clinical Hospital of Valencia, has collected this aid from the Spanish Association of Surgeons for multicentre prospective projects, endowed with 10,000 euros, in the Symphonic Hall of the Auditorium of the Provincial Council of Alicante during the XXIV National Surgery Meeting.